Technology News and Research

RSS

Hip arthroscopy system launched by DePuy Mitek

DePuy Mitek, Inc., a leading developer and manufacturer of orthopaedic sports medicine products and soft tissue repair devices, announced the launch of ENDURANCE Hip Solutions, a new system of instruments and devices that marks the company’s entry into the rapidly growing field of hip arthroscopy.

28 Sep 2012

U.S. Pharmacopeial announces winners of 2012-13 Global Fellowship awards

Since the program's inception more than thirty years ago, USP has invested nearly $4 million in over 200 fellowship awards.

28 Sep 2012

TRIL Centre announces Falls Awareness Day on Oct. 4

The TRIL Centre with Get Ireland Active announces Falls Awareness Day, Thursday 4th October 2012. One in three people over the age of 65 will fall every year in Ireland. Two-thirds of this group will fall again within six months, leading to risk of hospitalisation and significant health decline. As well as physical injuries suffered, the psychological and social consequences of falling can have a huge impact on the faller.

28 Sep 2012

Conditionally reprogrammed cells help identify effective therapy for HPV-positive RRP

Using a newly discovered cell technology, Georgetown University Medical Center researchers were able to identify an effective therapy for a patient with a rare type of lung tumor. The single case study, reported in the September 27 issue of New England Journal of Medicine, provides a snapshot of the new technology's promising potential; however, researchers strongly caution that it could be years before validation studies are completed and regulatory approval received for its broader use.

28 Sep 2012

Intellectual disability often results from genetic causes that are not inherited

New research published Online First in The Lancet suggests that a high proportion of severe intellectual disability results from genetic causes that are not inherited. These findings are good news for parents, indicating a low risk of passing on the disorder to further children.

28 Sep 2012

Inhibiting TRPV4 protects against diet-induced obesity, inflammation and insulin resistance

Ember Therapeutics, Inc., a company harnessing breakthroughs in brown fat biology and insulin sensitization to revolutionize the treatment of metabolic disease, today announced the publication of key preclinical data demonstrating that inhibition of the Transient Receptor Potential Vanilloid (TRPV) family of ion channels - specifically TRPV4 - resulted in activation of brown/beige fat and protection from diet-induced obesity, inflammation and insulin resistance. Ember holds an exclusive option to license these TRPV4 findings and technology.

28 Sep 2012

Molecular link between thermogenesis and development of inflammation in fat cells

Flipping a newly discovered molecular switch in white fat cells enabled mice to eat a high-calorie diet without becoming obese or developing the inflammation that causes insulin resistance, report scientists from Dana-Farber Cancer Institute.

28 Sep 2012

Boston Scientific receives CE MARK approval for Vercise DBS to treat Parkinson's

Boston Scientific Corporation received CE Mark approval for use of its Vercise Deep Brain Stimulation (DBS) System for the treatment of Parkinson's disease.

28 Sep 2012

Evidence does not support claims of Cogmed Working Memory Training

A target article in the Journal of Applied Research in Memory and Cognition concludes that evidence does not support the claims of Cogmed Working Memory Training. Additional experts weigh in with commentary papers in response.

28 Sep 2012

Janssen, Health 2.0 announce partnership

Today Janssen Healthcare Innovation (JHI), a team within Janssen Research & Development, LLC. (Janssen), announced the Janssen Connected Health Challenge Europe 2012 in partnership with Health 2.0.

28 Sep 2012

Private Healthcare Australia grants reimbursement code to IDEV’s SUPERA stent

IDEV Technologies, Inc. (IDEV), an emerging global innovator in peripheral devices, today announced that Private Healthcare Australia has granted the Company a reimbursement code for the SUPERA stent.

28 Sep 2012

Roundup: Md. Blues chief pans hospital costs shift plan; Pharmacies struggle with new drug controls

Negotiations to avert a breakdown in Maryland's unique system of regulating hospital prices have deteriorated into a stalemate between the state's largest insurer and the Maryland Hospital Association. CareFirst BlueCross BlueShield CEO Chet Burrell, speaking out for the first time about the talks, blames hospitals for their proposal to shift hundreds of millions in costs to CareFirst and other private insurers in an attempt to control rising Medicare spending.

28 Sep 2012

Competition between two brain regions influences the ability to make healthy choices

Almost everyone knows the feeling: you see a delicious piece of chocolate cake on the table, but as you grab your fork, you think twice. The cake is too fattening and unhealthy, you tell yourself. Maybe you should skip dessert.

27 Sep 2012

Combination of two neuroprotective therapies shows promise against Alzheimer's

The combination of two neuroprotective therapies, voluntary physical exercise, and the daily intake of melatonin has been shown to have a synergistic effect against brain deterioration in rodents with three different mutations of Alzheimer's disease.

27 Sep 2012

Hatch seeks more details from the Obama administration about federal exchanges

Sen. Orrin Hatch, R- Utah, charged that states can't make decisions about whether to pursue their own health insurance exchanges or to rely on the federal fallback version unless they have more information.

27 Sep 2012

STENTYS announces European commercial release of new Self-Apposing stent technology

STENTYS, a medical technology company commercializing the world's first and only self-apposing stent to treat Acute Myocardial Infarction (AMI), announced today the European commercial release of an enhanced stent-delivery system for its Self-Apposing stent.

27 Sep 2012

Karolinska Institutet scientists discover new approach to treat type II diabetes

An international team of scientists, led from Karolinska Institutet in Sweden, have discovered an entirely new approach to the treatment of type II diabetes. The therapy involves the blockade of signalling by a protein known as VEGF-B and this prevents fat from accumulating in the 'wrong' places, such as in muscles and in the heart. As a result the cells within these tissues are once again able to respond to insulin.

27 Sep 2012

Technology News and Research

Hip arthroscopy system launched by DePuy Mitek

U.S. Pharmacopeial announces winners of 2012-13 Global Fellowship awards

TRIL Centre announces Falls Awareness Day on Oct. 4

Conditionally reprogrammed cells help identify effective therapy for HPV-positive RRP

Intellectual disability often results from genetic causes that are not inherited

Inhibiting TRPV4 protects against diet-induced obesity, inflammation and insulin resistance

Molecular link between thermogenesis and development of inflammation in fat cells

Boston Scientific receives CE MARK approval for Vercise DBS to treat Parkinson's

Evidence does not support claims of Cogmed Working Memory Training

Janssen, Health 2.0 announce partnership

Private Healthcare Australia grants reimbursement code to IDEV’s SUPERA stent

Roundup: Md. Blues chief pans hospital costs shift plan; Pharmacies struggle with new drug controls

Competition between two brain regions influences the ability to make healthy choices

Combination of two neuroprotective therapies shows promise against Alzheimer's

Hatch seeks more details from the Obama administration about federal exchanges

STENTYS announces European commercial release of new Self-Apposing stent technology

Karolinska Institutet scientists discover new approach to treat type II diabetes

Loyola now offers sacral nerve stimulation for patients with fecal incontinence

New optical imaging technology could aid in breast cancer diagnosis and treatment

Prime Healthcare Services purchases Dallas Medical Center

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News